‘Start innovating like crazy’: Fast-moving genomics startup turns to R&D to navigate the pandemic
Phase Genomics, a Seattle-based life science company, that maps and analyzes genomes, is focusing its attention inward and renewing its R&D efforts during the pandemic.
According to Life Science Washington CEO, Dr. Leslie Alexandre, Phase Genomics is one of many companies adapting to COVID-19 challenges. In her conversation with GeekWire, she said, “Almost every company whose technology can be applied to COVID-19 has pivoted at least some of their R&D to this global challenge.”